| Followers | 11 |
| Posts | 1963 |
| Boards Moderated | 0 |
| Alias Born | 04/16/2024 |
Wednesday, October 16, 2024 12:34:46 PM
Finally,,,,,,,, "they" will water them all and things will get going. RNA in genetic diseases....
Recent WVE News
- Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1 • PR Newswire (US) • 05/19/2026 01:49:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/18/2026 08:51:59 PM
- Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing • GlobeNewswire Inc. • 05/18/2026 08:30:00 PM
- Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference • GlobeNewswire Inc. • 05/13/2026 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/07/2026 08:01:18 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 05/01/2026 08:21:56 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2026 08:15:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/28/2026 11:50:31 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 11:34:43 AM
- Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update • GlobeNewswire Inc. • 04/28/2026 11:30:00 AM
- Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2026 09:05:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/21/2026 08:49:30 PM
- Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States • GlobeNewswire Inc. • 04/21/2026 08:01:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/18/2026 01:00:05 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/18/2026 01:00:03 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/15/2026 08:13:46 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/15/2026 08:10:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 08:08:07 PM
- Wave Life Sciences Announces Proposed Redomiciliation to the United States • GlobeNewswire Inc. • 04/15/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 08:15:13 PM
- Wave Life Sciences shares plunge 30% despite encouraging obesity trial results • IH Market News • 03/26/2026 02:12:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 11:41:00 AM
- Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007 • GlobeNewswire Inc. • 03/26/2026 11:30:00 AM
